Collegium Pharmaceutical, Inc. drugs

3 results

  • nucynta

    (tapentadol hydrochloride)
    Collegium Pharmaceutical, Inc.
    NUCYNTA ER (tapentadol) is indicated for managing severe, persistent pain in adults requiring long-term opioid treatment when alternatives are inadequate, including neuropathic pain associated with diabetic peripheral neuropathy. It is not suitable for as-needed pain management due to addiction and misuse risks.
    Medication Details
    Drug Interactions

  • nucynta

    (tapentadol hydrochloride)
    Collegium Pharmaceutical, Inc.
    NUCYNTA (tapentadol) tablets are indicated for managing acute pain in adults and pediatric patients aged 6 years or older, weighing at least 40 kg, when alternative treatments are inadequate. Use is limited due to risks of addiction and should be for severe pain requiring opioid analgesics.
    Medication Details
    Drug Interactions

  • xtampza

    (OXYCODONE)
    Collegium Pharmaceutical, Inc.
    XTAMPZA ER is indicated for managing severe and persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not intended for as-needed (prn) use and should be prescribed cautiously due to risks of addiction, abuse, and overdose associated with opioids.
    Medication Details
    Drug Interactions